Last Friday, the fine people of the L.A.-based AIDS Healthcare Foundation dropped of some 1,593 letters at the offices of Gilead Sciences Inc., the world’s largest (and wealthiest) manufacturer of antiretroviral drugs, according to the Silicon Valley/San Jose Business Journal.
Nearly 10,000 Americans with HIV/AIDS languish — without proper medical care — on waiting lists because neither they nor state drug-assistance programs can afford the $10,000 a year price tag Gilead has slapped on its products.
No doubt individuals and companies that help produce these useful pharmaceuticals should be remunerated for their work, but as demand (read: people dying of HIV/AIDS) keeps getting better and better — with few or no competitors in the marketplace — and yet prices remain high or even rise, one begins to wonder….
Read the rest of the article here.
+++++++
Play Safe.
